Pharmacological Exploitation of Indole-3-Carbinol to Develop Potent Antitumor Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
398-404
Author(s):
J.-R. Weng, H.A. Omar, S.K. Kulp and C.-S. Chen
Fulvestrant - A Novel Endocrine Therapy for Breast Cancer
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
902-914
Author(s):
S. J. Johnston and K. L. Cheung
The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer
Journal:
Current Drug Targets
Volume:
11
Page:
474-481
Author(s):
D. Gallo, C. Ferlini and G. Scambia
Cell Responses to Oxidative Stressors
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1387-1395
Author(s):
Amelia Cataldi
Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1396-1409
Author(s):
V. Cepero, J. R. Sierra and S. Giordano
10 Years of SELDI: What Have we Learnt?
Journal:
Current Proteomics
Volume:
7
Page:
15-25
Author(s):
Wenbin Wei, Ashley Martin, Philip J. Johnson and Douglas G. Ward
Tubulin-Targeting Agents in Hybrid Drugs
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
609-639
Author(s):
E. C. Breen and J. J. Walsh
Valproic Acid in the Complex Therapy of Malignant Tumors
Journal:
Current Drug Targets
Volume:
11
Page:
361-379
Author(s):
J. Hrebackova, J. Hrabeta and T. Eckschlager
Tumor Markers: The Potential of “Omics” Approach
Journal:
Current Molecular Medicine
Volume:
10
Page:
249-257
Author(s):
M. Sikaroodi, Y. Galachiantz and A. Baranova
Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
584-596
Author(s):
G. Candore, C. Caruso, E. Jirillo, T. Magrone and S. Vasto